AM
Anna Mehlich
Internal Medicine
Credentials: ·
History
- 2023–2026
Internal Medicine
- 2019–2023
Medical School
Research
MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
Cell Death and Disease · 2021 · 25 citations
Medical treatment of Cushing's disease with concurrent diabetes mellitus
Review · Frontiers in Endocrinology · 2023 · First of 4 authors · 10 citations
Osilodrostat - an emerging drug for the medical management of Cushing's disease
Review · Endokrynologia Polska · 2022
2 papers · 1 as a resident